An ongoing study is attempting to build on what researchers have learned in recent years regarding neoadjuvant approaches to immunotherapy for high-risk melanoma.
Archive | Melanoma News
Garutti Examines Advantages of Neoadjuvant Approaches in Melanoma
The use of adjuvant therapies in melanoma could offer superior efficacy compared to what is currently provided by adjuvant therapies alone, with some preclinical data pointing to increased clinical benefit within this patient population, according to Mattia Garutti, MD.
Posted in Melanoma News, Health Professionals, Of Interest
Melanoma ‘calculator’ for skin cancer risk
Australians will now be able to determine their likelihood of developing melanoma in under a minute with a new lifetime risk ‘calculator’.
Posted in Melanoma News, Health Professionals, Of Interest
Predictors of long-term anxiety and depression in uveal melanoma survivors: A cross-lagged five-year analysis
Data were obtained from sample of 453 uveal melanoma survivors who completed observations 6?, 12?, 24?, 36?, 48? and 60?months postdiagnosis and missed no two consecutive observations.
Posted in Melanoma News, Publications, Scientific Publications
